Why the study?
BAV aortopathy is a common and heterogenous clinical problem where decision making around timing of intervention requires a personalized approach.
The 2022 guideline update emphasizes a personalized approach for the timing of intervention in bicuspid aortic valve associated aortopathy.
Guides personalized aortic intervention timing in bicuspid aortopathy; extends 2022 guidelines with multifactorial criteria.
BAV aortopathy is a common and heterogenous clinical problem. The decision making around timing of intervention requires a personalized approach that is based on the aortic dimensions, valve function, rate of growth, family history, patient factors, and surgical experience within MATs.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: